NEULAND LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,134 INR | -0.14% |
|
-5.39% | +34.93% |
| May. 10 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
| May. 10 | Neuland Laboratories Limited Recommends Final Dividend for the Financial Year 2023-24 | CI |
Presenter SpeechDiwakar Pingle (Attendees)Good evening, friends. Welcome to the Q2 FY '22 Earn...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Neuland Laboratories Limited is an India-based company, which is engaged in manufacturing and selling of bulk drugs. The Company caters to both domestic and international markets. It manufactures active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industryâs chemistry needs. The Company provide solutions across the full range of the pharmaceutical industryâs chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life cycle, as well as commercial launch. The Company operates through a single segment, manufacture of active pharmaceutical ingredients and allied services. The Company has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services.
Sector
Pharmaceuticals
Calendar
2024-05-14
- Q4 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7,134
INR
Average target price
8,300
INR
Spread / Average Target
+16.34%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +34.93% | 1.1B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- NEULANDLAB Stock
- News Neuland Laboratories Limited
- Transcript : Neuland Laboratories Limited, Q2 2022 Earnings Call, Oct 29, 2021